Cargando…
The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib-Induced Neuropathic Pain
The proteasome inhibitor bortezomib (BTZ) is a potent first-line anticancer drug for multiple myeloma; nonetheless, it induced peripheral neuropathy. It has been suggested that many cytokines may play a role in mediating neuropathic pain, but the underlying molecular mechanism is not fully understoo...
Autores principales: | Guo, Yan, Xu, Xiaobo, Huang, Jingyi, Wang, Zhen, Li, Zhenzhong, Liu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376423/ https://www.ncbi.nlm.nih.gov/pubmed/32733956 http://dx.doi.org/10.1155/2020/8143754 |
Ejemplares similares
-
p38 MAPK, microglial signaling, and neuropathic pain
por: Ji, Ru-Rong, et al.
Publicado: (2007) -
Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion
por: Qu, Yu-Juan, et al.
Publicado: (2016) -
Silencing P2X7R Alleviates Diabetic Neuropathic Pain Involving TRPV1 via PKCε/P38MAPK/NF-κB Signaling Pathway in Rats
por: Chen, Lisha, et al.
Publicado: (2022) -
Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model
por: Yu, Chao, et al.
Publicado: (2020) -
Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain
por: Lee, Min K, et al.
Publicado: (2011)